In conclusion, our results demonstrate that Nox2 containing NADPH oxidase critically contributes to ischemic BBB damage, and inhibiting Nox2 is an important mechanism underlying NBO-afforded BBB protection in transient cerebral ischemia and reperfusion. The gene discussed is FMO5; the disease is transient ischemic attack.